What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland

Author:

McCabe Holly M.1ORCID,Smrke Alannah2ORCID,Cowie Fiona3,White Jeff3,Chong Peter4,Lo Steven5ORCID,Mahendra Ashish5,Gupta Sanjay5,Ferguson Michelle6,Boddie David7,Mmekka Walter8,Stirling Lorraine3,Campbell Lindsay3,Jones Robin L.29ORCID,Nixon Ioanna13

Affiliation:

1. Department of Management Science, University of Strathclyde, Glasgow, United Kingdom

2. The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom

3. Scottish Sarcoma Network, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

4. Scottish Sarcoma Network, Gartnavel General Hospital, Glasgow, United Kingdom

5. Scottish Sarcoma Network, Glasgow Royal Infirmary, Glasgow, United Kingdom

6. Scottish Sarcoma Network, Ninewells Hospital, Dundee, United Kingdom

7. Scottish Sarcoma Network, Aberdeen Royal Infirmary, Aberdeen, United Kingdom

8. Scottish Sarcoma Network, Raigmore Hospital, Inverness, United Kingdom

9. The Institute of Cancer Research, London, United Kingdom

Abstract

PURPOSE In Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rapid changes into the care for patients with cancer, with increasing utilization of telemedicine. We aimed to evaluate how the utilization of telemedicine affects professionals and patients across Scotland and care delivery, at the Beatson West of Scotland Cancer Centre Sarcoma Unit. METHODS Between June 8 and August 25, 2020, we invited patients and professional sarcoma multidisciplinary team members to participate in separate online anonymous survey questionnaires, to assess their attitudes toward telemedicine. Data were extracted, and descriptive statistics were performed. RESULTS Patient satisfaction (n = 64) with telemedicine was high (mean = 9.4/10) and comparable with traditional face-to-face appointments (mean = 9.5/10). Patients were receptive to the use of telemedicine in certain situations, with patients strongly opposed to being told bad news via telemedicine (88%). Providers recommended the use of telemedicine in certain patient populations and reported largely equivalent workloads when compared with traditional consultations. Providers reported that telemedicine should be integrated into regular practice (66%), with patients echoing this indicating a preference for a majority of telemedicine appointments (57%). CONCLUSION Telemedicine in sarcoma care is favorable from both clinician and patient perspectives. Utilization of telemedicine for patients with rare cancers such as sarcomas is an innovative approach to the delivery of care, especially considering the time and financial pressures on patients who often live a distance away from specialist centers. Patients and providers are keen to move toward a more flexible, mixed system of care.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3